Great company - Recensione dipendente - Senior Manager presso Oncorus

5,0
29 lug 2023
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Great company, innovative cancer immunotherapy platform

Svantaggi

Suffered the fate of many biotech startups in a tough investment envirnoment

Esplora altre recensioni su Oncorus

5,0
1 mag 2024
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

this is a high pay

Svantaggi

this company no longer exists

4,0
4 gen 2025
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Collaboration between different departments for common goal

Svantaggi

Leadership didn’t always agree with each other

Vedi recensioni per: Utile|Valutazione|Data|Tutto